612 related articles for article (PubMed ID: 21985975)
1. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling.
Aghaloo TL; Pirih FQ; Shi A; Bezouglaia O; Tetradis S
J Periodontol; 2006 Jan; 77(1):21-30. PubMed ID: 16579699
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
Goltzman D
Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
[TBL] [Abstract][Full Text] [Related]
6. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of bone anabolic action by PTH].
Kaji H
Clin Calcium; 2012 Mar; 22(3):321-6. PubMed ID: 22370298
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of RGS-2 by constant and oscillating PTH concentrations.
Hömme M; Schaefer F; Mehls O; Schmitt CP
Calcif Tissue Int; 2009 Apr; 84(4):305-12. PubMed ID: 19225708
[TBL] [Abstract][Full Text] [Related]
9. [Parathyroid hormone and Wnt signaling].
Tamura Y; Kaji H
Clin Calcium; 2013 Jun; 23(6):847-52. PubMed ID: 23719497
[TBL] [Abstract][Full Text] [Related]
10. Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells.
Reppe S; Olstad OK; Rian E; Gautvik VT; Gautvik KM; Jemtland R
Biochem Biophys Res Commun; 2004 Nov; 324(1):218-23. PubMed ID: 15465005
[TBL] [Abstract][Full Text] [Related]
11. [Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].
Ogata N; Kawaguchi H
Clin Calcium; 2007 Dec; 17(12):1843-9. PubMed ID: 18057659
[TBL] [Abstract][Full Text] [Related]
12. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
14. [Biological function of bone cells on the PTH-driven anabolic effect].
Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
[TBL] [Abstract][Full Text] [Related]
16. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
17. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
Wang Y; Qin QH; Kalyanasundaram S
Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
[TBL] [Abstract][Full Text] [Related]
18. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
Tobimatsu T; Kaji H; Sowa H; Naito J; Canaff L; Hendy GN; Sugimoto T; Chihara K
Endocrinology; 2006 May; 147(5):2583-90. PubMed ID: 16484320
[TBL] [Abstract][Full Text] [Related]
20. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
Wang L; Quarles LD; Spurney RF
J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
